Edwards Lifesciences to spin off critical-care unit, sets $1B stock buyback By: MarketWatch December 07, 2023 at 12:06 PM EST Katie Szyman will be chief executive of the independent company, which is expected to generate $905 million in sales in 2023. Read More >> Related Stocks: Edwards Lifesciences
